Skip to content
Finance Investment, Oil Mining Resources

Galan Lithium (ASX:GLN) – Maiden Filling of Pond 1 Commences at Hombre Muerto West

Galan Lithium Limited (ASX:GLN) 2 mins read

Galan Lithium Limited (ASX:GLN) ("Galan" or the "Company"), an ASX-listed lithium exploration and development business, is pleased to provide an update on the significant progress of its Hombre Muerto West (HMW) Phase 1 lithium brine project. The Company is on track to commence lithium chloride production in the first half of 2025.

 

Key Project Highlights:

  • Commencement of Pond 1 Filling: The initial filling of Pond 1 at the HMW Project marks a significant milestone in the project's development.
  • Evaporation Process Initiation: The evaporation process, a critical component of lithium production, is set to begin within two weeks following the completion of quality testing.
  • Rapid Progress in Construction: The liner installation in Pond 1 has achieved 40% completion, while Pond 2's earthworks construction is 20% complete.
  • Premium Grade Lithium Chloride Production: The HMW Project is poised to produce a high-grade lithium chloride concentrate of 6% Li, equivalent to 13% Li2O or 32% Lithium Carbonate Equivalent (LCE), positioning it as a tier-one project in the industry.
  • Competitive Cost Structure: With an operating cost of $US3,510/t LCE, translating to a low Li2O equivalent operating cost of SC6 $US310/t-$US350/t, HMW is positioned in the 1st quartile of the lithium industry’s cost curve.
  • Resource Estimate Update: An updated resource estimate for the HMW Project is scheduled for release in Q1 2024.

Phased Production Strategy:

The HMW project is structured into four production phases. The initial Phase 1 Definitive Feasibility Study (DFS) is focused on producing 5.4ktpa LCE of lithium chloride concentrate by H1 2025. Subsequent phases include:

  • Phase 2: Targeting 21ktpa LCE in 2026.
  • Phase 3: Aiming for 40ktpa LCE by 2028.
  • Phase 4: Projected to reach 60ktpa LCE by 2030, incorporating lithium brine from both HMW and Galan’s Candelas project.

The promising results of the Phase 2 DFS, announced on 3 October 2023, underscore the project's potential and scalability.

 

Galan’s Managing Director, Juan Pablo (JP) Vargas de la Vega, commented:

 

“Our experienced project team have been implementing a quicker route to start evaporation while construction continues for HMW Phase 1. We are taking advantage of the summer season whereby a buffer wall has been installed at the one third mark of Pond 1. The commencement of the filling of Pond 1 is another significant major milestone for the HMW project and I congratulate the entire Galan team. The initial partial evaporation process will commence in approximately 14 days with the full fill of Pond 1 remaining on track for Q1 2024.” 


About us:

Galan Lithium Limited (ASX:GLN) is an ASX-listed lithium exploration and development business. Galan’s flagship assets comprise two world-class lithium brine projects, HMW and Candelas, located on the Hombre Muerto Salar in Argentina, within South America’s ‘lithium triangle’. Hombre Muerto is proven to host lithium brine deposition of the highest grade and lowest impurity levels within Argentina. It is home to the established El Fenix lithium operation (Livent Corporation) and the Sal de Vida (Allkem) and Sal de Oro (POSCO) lithium projects. Galan is also exploring at Greenbushes South in Western Australia, approximately 3 km south of the Tier 1 Greenbushes Lithium Mine.


Contact details:

Jane Morgan

[email protected]

Media

More from this category

  • Finance Investment
  • 13/01/2026
  • 13:40
Moomoo

Focused on AI, Australian investors expect 2026 to deliver

SYDNEY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Australian investors have started the new year with an overwhelming appetite for artificial intelligence and expectations of solid returns from their increasingly global portfolios, a comprehensive new survey by stock broking firm Moomoo Australia and New Zealand reveals.The detailed survey of more than 600 Australian investors' expectations and intentions for the year complements the release of moomoo's 2026 Market Outlook today, where our local experts and global research team analyse key trends in financial markets for the year ahead.And this year, investors are committing to high-growth sectors, including AI – showing a willingness…

  • Finance Investment, Oil Mining Resources
  • 13/01/2026
  • 10:22
Jane Morgan Management

Patriot Resources reports significant silver and gold results validating Kitumba polymetallic target in Zambia

Perth, Australia – 13 January 2026: Patriot Resources Limited (ASX: PAT) has reported significant silver and gold assay results from its Phase 1 trenching program at Target B1 within the Company’s 80%-owned Kitumba 27715 Project in Zambia, further validating the prospect as a near-surface polymetallic system. The latest results add silver and gold credits to previously announced strong copper, zinc and lead geochemistry, reinforcing the scale and potential economic significance of the mineralised system. The Company said the combination of metals highlights a unique polymetallic signature and strengthens confidence in Target B1 as a priority focus for ongoing exploration. Notable…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 13/01/2026
  • 10:09
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Reports Clinical Response for StemSmart(TM) Treatment in Fistulising Crohn’s Disease Under Special Access Program

13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access Program demonstrated a successful “Clinical Response” following treatment with StemSmart™, with the fourth patient showing a partial response with further clinical assessment needed. A Clinical Response is defined as either closure of at least 50 per cent of fistula openings or a reduction in fistula…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.